Related Experiment Video
Updated: Feb 9, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients
M Bodro1, G Sanclemente1, G Crespo2
1Infectious Diseases Department, Hospital Clínic-IDIBAPS-CIBERHED, University of Barcelona, Barcelona, Spain.
Severe hepatitis C virus (HCV) recurrence after liver transplant increases the risk of opportunistic infections (OI), particularly cytomegalovirus and fungal infections. Vigilance for OI is crucial in these patients.
Area of Science:
- Hepatology
- Transplant Surgery
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) recurrence is a significant concern in liver transplant recipients.
- Severe recurrence (SR) may impact post-transplant outcomes and infection risk.
Purpose of the Study:
- To determine clinical characteristics, OI frequency, and outcomes in liver transplant recipients with severe HCV recurrence.
- To evaluate HCV recurrence as a risk factor for developing opportunistic infections.
Main Methods:
- Retrospective observational study of liver transplant recipients from 2003-2012.
- Patients with HCV liver disease were selected and monitored for infections.
- Classification based on the presence of severe HCV recurrence.
Main Results:
- 370 patients with chronic HCV underwent liver transplantation; 49% had severe recurrence (SR).
- Patients with SR had higher rates of opportunistic infections (OI), especially cytomegalovirus (CMV) and fungal infections (33% vs 13%).
- Acute allograft rejection, donor age ≥60, and SR were independently associated with OI development.
Conclusions:
- Maintain a high index of suspicion for OI in liver transplant recipients with severe HCV recurrence.
- Consider active surveillance for CMV infection and prophylactic strategies against OI.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Relative Risk
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

